Taking charge
Both in the hospital and with students, Tesoro, Mucksavage and Kim continue to show themselves as leaders, clinicians capable of improving results. “It takes a team of diverse and collaborative clinicians to get treatment started and drive better outcomes,” Tesoro says. “We try to advance care by getting everyone on the same page.”
“We come in with a different
point
of view, which is particularly important in neurocritical care given how many needs these
Each member of the trio, meanwhile, continues pursuing research in the rapidly evolving neuroscience field.
patients have that are different than the regular
Tesoro directs much of his research toward the treatment of strokes, though he often involves himself in residents’ projects as well. This year, for example, Tesoro is tackling projects examining the role of pharmacists on hospital stroke teams as well as the relationship between medication adherence and outcomes in stroke patients.
hospital population.” JEFFREY MUCKSAVAGE
Kim focuses much of her research on homeostasis and thrombosis, looking specifically at incidents of blood clots in hospital patients and the use of homeostatic agents for those with bleeding in the head. Mucksavage collaborates with Kim on homeostatic agent projects, but also investigates adverse events from the quality side, including automating reports. All three are also members of the Neurocritical Care Society, a professional forum for exchanging ideas and developing best practices. Tesoro, in fact, chairs the Society’s pharmacist group. It’s spirited work that energizes and inspires the three longtime colleagues. “With neurocritical care, we’re in a dynamic field that’s at the cutting edge of evidence-based medicine and that’s what makes this work so exciting,” Tesoro says. “We know we’re helping to improve patient outcomes while also passing important knowledge to the next generation of pharmacists.”
The Pharmacist | 21